Catalyst
Slingshot members are tracking this event:
Phase 3 program of filgotinib in Crohn’s disease and the Phase 2/3 program in ulcerative colitis are underway for a start later this year
- Source Link:
- http://www.glpg.com/docs/view/579a64f3e13fc-en
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GLPG |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 22, 2016
Occurred Source:
http://www.glpg.com/docs/view/58349050acf95-en
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Crohn's Disease, Ulcerative Colitis, Filgotinib
